There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on AbbVie (ABBV – Research Report), Wave Life Sciences (WVE – Research Report) and Edwards Lifesciences (EW – Research Report) with bullish sentiments.
AbbVie (ABBV)
In a report released today, Srikripa Devarakonda from Truist Financial maintained a Buy rating on AbbVie. The company’s shares closed last Friday at $159.62.
According to TipRanks.com, Devarakonda is a 4-star analyst with an average return of
AbbVie has an analyst consensus of Strong Buy, with a price target consensus of $179.50, representing a 7.4% upside. In a report issued on April 22, Piper Sandler also maintained a Buy rating on the stock with a $185.00 price target.
See today’s best-performing stocks on TipRanks >>
Wave Life Sciences (WVE)
In a report released today, Joon Lee from Truist Financial assigned a Buy rating to Wave Life Sciences, with a price target of $17.00. The company’s shares closed last Friday at $4.66.
According to TipRanks.com, Lee is a 5-star analyst with an average return of
Wave Life Sciences has an analyst consensus of Strong Buy, with a price target consensus of $13.20, representing a 175.0% upside. In a report issued on April 23, Mizuho Securities also maintained a Buy rating on the stock with a $19.00 price target.
Edwards Lifesciences (EW)
In a report released today, Richard Newitter from Truist Financial maintained a Buy rating on Edwards Lifesciences. The company’s shares closed last Friday at $86.43.
According to TipRanks.com, Newitter is a 5-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Edwards Lifesciences with a $95.80 average price target, implying a 10.1% upside from current levels. In a report issued on April 15, RBC Capital also maintained a Buy rating on the stock with a $101.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on ABBV:
